Keywords: GlaxoSmithKline, Intercell, Needle-free patch vaccines, Influenza, Licensing, Equity stake

GlaxoSmithKline in deal with Intercell on needle-free patch-based vaccines

Article | 11 December 2009

Print This

Austrian vaccine maker Intercell and GlaxoSmithKline Biologicals SA, the vaccines subsidiary of UK drug giant GSK, have agreed to form ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in